Baxter International Inc.
BAX
#1583
Rank
$13.700 B
Marketcap
United States
Country
$26.50
Share price
-4.02%
Change (1 day)
2.20%
Change (1 year)
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals;…
Key Metrics
Trailing P/E
—
Forward P/E
11.55
EPS (TTM)
$-1.88
Forward EPS
$2.04
Price / Book
1.96
EV / EBITDA
10.5x
Beta
0.59
Dividend Yield
0.17%
Return on Equity
-14.37%
Return on Assets
2.85%
Debt / Equity
156.45
Current Ratio
1.95
Gross Margin
34.10%
Operating Margin
14.43%
Net Profit Margin
-9.27%
Free Cash Flow
$1.000B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 17 – Sep 16
-9.20%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$11.244B
Latest Net Income$-957,000,000
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Baxter International Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
BAX
No recent news available. Set FINNHUB_API_KEY to enable news.
